Drug Classification
Butyrophenone Antipsychotic/Neuroleptic
Mechanism of Action
Mesolimbic D1/D2 antagonist ->depresses release of hypothalamic and hypophyseal hormones; depresses the reticular activating system, thus affecting basal metabolism, body temperature, wakefulness, vaso motor tone and emesis
Pharmacokinetics
Onset of Action- 30-45 minutes
Peak Effects- 10-20 minutes
Duration of Effects- varies
Half-Life- 3-35 hours
Indications/Field Use
Acute psychosis episode
Contraindications
- Agitation secondary to shock or hypoxia
Side Effects/Adverse Reactions
EPS Insomnia/Restlessness/Drowsiness Seizures/Dry mouth/Constipation Respiratory Depression Tachycardia/Hypotension/Prolonged QT syndrome: Torsades
Dose
Adult:
5mg IM q 4-8 hours PRN
Pedi:
1-3mg IM q 4-8 hours PRN, MAX 0.15mg/kg/day
Precautions
Drug-Drug Interactions